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J Appl Physiol 103: 425–431, 2007. First published April 26, 2007;
doi:10.1152/japplphysiol.00157.2007.—The consumption of nonste-
roidal anti-inflammatory drugs (NSAIDs) is widespread among ath-
letes when faced with muscle soreness or injury, but the effects of
NSAIDs on satellite cell activity in humans are unknown. To inves-
tigate this, 14 healthy male endurance athletes (mean peak oxygen
consumption 62 ml kg1 min1) volunteered for the study, which
involved running 36 km. They were divided into two groups and
received either 100 mg indomethacin per day or placebo. Muscle
biopsies collected before the run and on days 1, 3, and 8 afterward
were analyzed for satellite cells by immunohistochemistry with the
aid of neural cell adhesion molecule (NCAM) and fetal antigen-1
(FA1) antibodies. Muscle biopsies were also collected from untrained
individuals for comparison. Compared with preexercise levels, a 27%
increase in the number of NCAM cells was observed on day 8
postexercise in the placebo group (P  0.05), while levels remained
similar at all time points in the NSAID group. No change was seen in
the proportion of FA1 cells, although lower levels were found in the
muscle of endurance-trained athletes compared with untrained indi-
viduals (P  0.05). These results suggest that ingestion of anti-
inflammatory drugs attenuates the exercise-induced increase in satel-
lite cell number, supporting the role of the cyclooxygenase pathway in
satellite cell activity.
skeletal muscle; nonsteroidal anti-inflammatory drug; running; neural
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SATELLITE CELLS are crucial for skeletal muscle adaptation to
exercise. They contribute to hypertrophy by providing new
myonuclei and repair damaged segments of mature myofibers
for successful regeneration following injury or exercise-in-
duced muscle damage (13–15, 40). While there is ample
evidence to show that exercise can stimulate satellite cells to
re-enter the cell cycle and proliferate, reviewed by Kadi et al.
(20), the mechanisms by which this activation occurs are not
yet fully understood (3). It has been reported that cyclooxy-
genase (COX) is necessary for satellite cell activity (31) and
muscle regeneration (2, 4), and furthermore, it has been shown
that inhibition of COX activity by ingestion of nonsteroidal
anti-inflammatory drugs (NSAIDs) suppresses the increased
mixed muscle protein synthesis rates normally observed fol-
lowing exercise (46). Such an observation is clinically relevant
given the widespread consumption of NSAIDs among athletes
(27, 48).
There are many reports of the effects of different types of
exercise on satellite cells in old and young individuals of
different training status (summarized in Table 1). Studies
examining the effects of a single bout of exercise involving
high force eccentric muscle contractions, for example, have
revealed significant increases in the number of satellite cells
shortly after exercise (9, 10). Regular repeated training over
longer periods has also been investigated and, while similar
numbers of satellite cells were reported with 8–16 wk of
strength training (16), other studies have found significant
increases in satellite cell number in both young and old
individuals (6, 21, 26, 35, 38). As can be seen from the
summary of these studies in Table 1, a single bout of maximal
eccentric contractions on an isokinetic dynamometer induces a
much stronger satellite cell response than a period of regular
strength training, possibly reflecting the requirement of satel-
lite cell activity in the processes of regeneration and hypertro-
phy, respectively. There is, however, a lack of information on
the effects of a single bout of exercise in well-trained athletes,
as all of the previously mentioned studies involved untrained
subjects for whom the exercise was unaccustomed. With this in
mind, the present study was designed to examine the influence
of NSAIDs on satellite cells and their response to exercise in
well-trained humans.
A secondary aim of the present study was to compare two
markers of satellite cells, as there are many different markers
currently in use but no consensus as to which is the most
reliable. Neural cell adhesion molecule (NCAM; also known as
CD56 or Leu19) has been used in many studies to identify
satellite cells (see Table 1). Another potential marker of satel-
lite cells is fetal antigen-1 (FA1), whose larger membrane-
associated precursor is known as human delta-like (dlk). FA1
is a member of the growth factor superfamily and believed to
be a marker of cells with regenerative potential (12). While
increased numbers of FA1 cells were observed in skeletal
muscle biopsies in response to a single bout of high-intensity
exercise involving eccentric contractions (9), the significance
of FA1 staining of satellite cells remains unclear. To our
knowledge there have not yet been any studies investigating
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the extent of colocalization of NCAM and FA1, and this study
therefore examined the colocalization of these two proteins in
muscle biopsies obtained from trained and untrained individ-
uals and also assessed the influence of exercise on this colo-
calization. We hypothesized that 36-km running in trained
individuals would influence the satellite cell pool and that the
ingestion of NSAIDs would alter this response. With regard to
FA1 and NCAM colocalization, our hypothesis was that
trained and untrained individuals would display different stain-
ing patterns.
METHODS
Volunteers and exercise. Fourteen endurance-trained athletes
[mean age 25  3 (SD) yr; height 1.83  0.06 m; weight 79  9 kg;
peak oxygen consumption (V˙ O2 peak) 62  6 ml kg1 min1] volun-
teered for the study, which involved running a 36-km race and the
collection of muscle biopsies before the race and on days 1, 3, and 8
afterward. One of the criteria for participation in the study was that the
individual had not taken NSAID during the 6 mo before the study. The
subjects were randomly assigned to two groups: one group received
NSAID (100 mg indomethacin per day) from 4 days before the run
until the final biopsy was collected, while the second group received
a placebo over the same period. To avoid any effect of NSAID
ingestion on baseline measurements, the prebiopsy was collected at
least 7 days before the run. Subjects were asked to refrain from
physical exercise for 10 days before the run. Muscle biopsies were
also collected from a second group of 12 healthy untrained males
[mean age 25  3 (SD) yr, height 1.83  0.06 m, and weight 81 
14 kg] as a control group for the FA1 staining analysis. All partici-
pants gave written informed consent for the study, which was ap-
proved by the Ethics Committees of the Municipalities of Copenhagen
and Frederiksberg (Ref no. KF 01-164/97) and conformed to the
Declaration of Helsinki.
Muscle biopsies. Muscle biopsies were obtained from the midpor-
tion of vastus lateralis muscle using a standard needle biopsy tech-
nique. For the individuals involved in the 36-km run, four biopsies in
total were collected from each person. Biopsies were taken from
alternate legs, the second biopsy from each leg being taken 5 cm
away from the incision site of the first biopsy. On extraction, the
sample was mounted and frozen by immersion in isopentane pre-
cooled to approximately 160°C by liquid nitrogen. Samples were
stored at 80°C pending analyses. Serial transverse sections (10 m)
were cut at 24°C using a cryostat and mounted on SuperFrost Plus
slides (Menzel-Gla¨ser, Braunschweig, Germany).
Immunohistochemistry. Satellite cells were visualized by immuno-
histochemical staining using a mouse anti-human NCAM antibody
(CD56, cat. no. 347740; Becton Dickinson, San Jose, CA), following
a previously described protocol (6). Counting was carried out on
842  396 fibers (mean  SD), 227 being the minimum number of
fibers in any of the biopsies examined. Values were expressed relative
to the number of myonuclei [NCAM cells/(myonuclei  NCAM
cells)  100].
To examine NCAM/FA1 colocalization, double staining was car-
ried out on two serial transverse sections (10 m) from each biopsy.
The first section was stained with mouse anti-human NCAM and
rabbit anti-human FA1 (developed at University of Southern Den-
mark, Odense, Denmark) antibodies to examine the extent of colo-
calization. The second section was stained for merosin (Clone Mer3/
22B2; Novocastra, Newcastle upon Tyne, UK) and FA1 to establish
the location of the FA1 cells. Merosin is a muscle-specific laminin
located in the basement membrane (41). Double staining with merosin
and FA1 allows determination of whether the cells are located within
this muscle-defined border or between the fibers in the extracellular
matrix (see Fig. 1). The staining protocol was as follows. Sections
were incubated overnight at 4°C with the first primary antibody
(NCAM or merosin), followed by Alexa Fluor 568 goat anti-mouse
secondary antibody (Molecular Probes cat. no. A11031; Invitrogen
A/S, Taastrup, Denmark). The second primary antibody (FA1) was
then applied overnight at 4°C, followed by incubation with Alexa
Fluor 488 goat anti-rabbit secondary antibody (Molecular Probes cat.
no. A11034; Invitrogen A/S). Sections were mounted with Molecular
Probes ProLong Gold antifade reagent with 4,6-diamidino-2-phe-
nylindole (DAPI) (cat. no. P36935; Invitrogen A/S). The number of
cells that were positive for both FA1 and NCAM were expressed
relative to the total number of NCAM cells or relative to myo-
nuclear number.
Table 1. Summary of recent human studies investigating the response of satellite cells to exercise
Exercise Participants Satellite Cell Identification Changes in Satellite Cell Number pRef. No.
Single biopsy Elite power lifters vs.
controls
NCAM 70% more satellite cells in
power lifters than controls
Kadi et al. (23)
Single biopsy High-level power lifters NCAM 	100% more satellite cells than
reports for untrained
Eriksson et al. (11)
Single bout: eccentric
exercise
Untrained young and old men NCAM 1141% (young), 151% (old)
24 h postexercise
Dreyer et al. (10)
Single bout: eccentric
exercise
Untrained young men NCAM 1192% 4 days postexercise Crameri et al. (9)
Single bout: 36-km run Endurance-trained young men NCAM 127% 8 days postexercise Present study
14-wk Endurance training Active old men NCAM 129% Charifi et al. (6)
9-wk Strength training Young and old men and
women
EM 135% Roth et al. (38)
10-wk Strength training Young women NCAM 146% Kadi and Thornell (22)
12-wk Strength training Untrained old men and
women
NCAM 127% Mackey et al. (26)
14-wk Strength training Untrained young men NCAM 131% Kadi et al. (21)
16-wk Strength training Untrained young men NCAM 1, further enhanced with creatine
supplementation
Olsen et al. (34)
16-wk Strength training Untrained young and old men
and women
NCAM 1in young men only Petrella et al. (35)
8- or 16-wk Strength training Young and old men EM No change Hikida et al. (16)
Analysis was carried out by immunostaining of muscle biopsy cross sections with an anti-neural cell adhesion molecule (NCAM) antibody or by electron
microscopy (EM). Percent changes presented are based on values presented in the original articles, where satellite cell number is expressed relative to fiber
number or number of nuclei.
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Regeneration was investigated with an antibody against embryonic
myosin (F1.652, Developmental Studies Hybridoma Bank, Iowa, IA).
The same sections were double stained with a polyclonal dystrophin
antibody (cat. no. ab15277; Abcam, Cambridge, UK) to visualize fiber
borders, following the double-staining protocol as described above.
The number of centrally located nuclei was also recorded from these
sections.
Statistics. Statistical analyses were performed using GraphPad
Prism version 4.0c for Macintosh (GraphPad Software, San Diego,
CA). Statistical significance was accepted at the 0.05 level. Data were
tested for normal distribution with the Kolmogorov-Smirnov normal-
ity test. Data were analyzed using a two-way repeated-measures
ANOVA. One-way repeated-measures ANOVA was used to deter-
mine changes over time for each group, and where an overall signif-
icant difference was observed, Dunnett’s multiple comparison test
was employed to determine which time points differed. Unpaired
t-tests were used to compare baseline characteristics of the placebo
and NSAID groups. Data are presented as means  SD.
RESULTS
Placebo and NSAID groups were similar with regard to age,
height, weight, and V˙ O2peak and completed the 36-km running
in similar times: 160  23 and 163  17 min, respectively. Of
the seven subjects in each group, a full set of muscle biopsies
(preexercise, 24 h, 3 day, and 8 day) was analyzed for six
subjects in the placebo group and five subjects in the NSAID
group. The exclusion of three subjects was due to either a
subject missing a biopsy time point or poor quality of one or
more of the biopsies obtained from a subject.
Satellite cells
Satellite cell data expressed relative to myonuclear number
are displayed in Table 2. Statistical analysis of these data using
the Kolmogorov-Smirnov normality test revealed nonnormal
distribution of total NCAM data for the 8-day time point in
the NSAID group. To conform the data to a Gaussian distri-
bution, the values were expressed relative to preexercise val-
ues, which passed the normality test. These adjusted data are
presented in Fig. 2. Two-way repeated-measures ANOVA
analysis of the adjusted data revealed no interaction between
the placebo and NSAID groups but an overall significance for
time (P 
 0.016). One-way repeated-measures ANOVA anal-
ysis showed a significant difference in the placebo group (P 

0.014), while no change was observed in the NSAID group
(P 
 0.384). Post hoc testing of the placebo group data
identified day 8 as being significantly different from preexer-
cise values (P 0.05), increasing by 27% from 4.10 0.86 to
5.14 1.08 on day 8. Repeated-measures ANOVA analysis of
Fig. 1. Pictures taken from 3 different sections. Nuclei are visible by blue
4,6-diamidino-2-phenylindole (DAPI) staining in A, C, and E. A and B are
images from double staining of the same section with neural cell adhesion
molecule (NCAM; A) and fetal antigen-1 (FA1; B), showing staining of a cell
positive for both NCAM and FA1 (*), and a likely myotube () positive only
for NCAM. FA1 cells were observed both outside (C and D) and inside (E
and F) merosin-defined muscle borders (*), as shown (D and E, merosin 
DAPI; E and F, FA1). A and B are 40 magnification; and C–F are 60
magnification.
Table 2. Satellite cell counts from vastus lateralis muscle obtained before and 24 h, 3 days, and 8 days after a 36-km run
from individuals who either consumed placebo or NSAID
Preexercise 24 h 3 Day 8 Day
Total NCAM
Placebo 4.100.86 4.140.32 4.971.21 5.141.08*
NSAID 4.210.97 3.840.62 4.490.74 4.070.86
FA1 and NCAM
Placebo 2.311.73 2.681.69 2.371.30 2.851.96
NSAID 2.890.96 2.511.27 3.312.11 2.031.39
Central nuclei fibers, %
Placebo 0.510.27 1.050.78 1.352.18 1.691.88
NSAID 1.041.12 1.240.69 1.060.74 1.371.60
Embryonic myosin fibers, %
Placebo 0.000.00 0.000.00 0.030.05 0.170.22
NSAID 0.010.02 0.070.12 0.010.04 0.020.04
Values are means  SD; n 
 5 subjects who consumed placebo and 5 subjects who consumed nonsteroidal anti-inflammatory drug (NSAID). Satellite cell
values are presented in 2 ways: as the number of NCAM cells (total NCAM) and as the number of cells positive for both NCAM and fetal antigen-1 (FA1
and NCAM), both expressed relative to myonuclear number. The percentage of fibers that contained centrally located nuclei or cytoplasmic staining for
embryonic myosin is also included. Values are means  SD. *Significantly different from preexercise values, P  0.05.
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the numbers of NCAM and FA1 cells presented in Table 2
showed similar levels at each time point.
FA1 staining. The FA1 staining pattern was a fine delinea-
tion of the cell border, similar to NCAM staining, and from the
NCAM/FA1 double staining, it was apparent that the staining
patterns of these two antibodies were almost identical: differ-
ences could only be observed at 60 magnification or higher.
Some cells stained very intensely, but these were rare. Figure
1 shows staining images from double staining with NCAM and
FA1, and merosin and FA1. On analysis of the relative pro-
portion of FA1 cells with the 36-km run, no effect was
observed over time (see Table 2). Figure 3 displays the pro-
portion of NCAM cells stained by FA1, showing clearly that
untrained individuals have a higher proportion than endurance-
trained individuals (73  12% compared with 48  18%,
respectively). Of all cells counted (either positive for NCAM
alone, FA1 alone, or both), 19  15% were positive for FA1
only. This value was identical for both trained and untrained
groups. To find out more about these cells, double staining for
merosin and FA1 was carried out, and this allowed us to
determine the proportion of FA1 cells located inside or
outside the basement membrane. In the untrained group, 26 
21% of all FA1 cells were found to be located outside the
merosin-defined muscle borders compared with 35  22% in
the trained group (not significant). Correlations between the
location of FA1 cells and the NCAM/FA1 double-staining
results are presented in Fig. 4 and show a strong positive
relationship between FA1 cells that are located outside mer-
osin-defined muscle borders and cells that are positive for FA1
but negative for NCAM. Similarly, those cells that are positive
for both NCAM and FA1 demonstrate a strong positive rela-
tionship with the FA1 cells located inside merosin-defined
muscle borders.
Regeneration. The number of fibers positive for embryonic
myosin was assessed for each section, and the result is ex-
pressed as a percentage of the total number of fibers in the
section. The results are presented in Table 2, and the values
ranged from 0 to 0.52%. Of the total of 16 embryonic fibers
observed from all the sections studied, 5 of those demonstrated
normal dystrophin staining, while the dystrophin staining
around the other 11 fibers was either very faint or completely
absent. The number of fibers with centrally located nuclei (see
Table 2) ranged from 0 to 6%. There was no significant change
with time or interaction between the placebo and NSAID
Fig. 4. Pearson’s correlations from 2 sets of double staining: merosin  FA1,
and NCAM  FA1. All data are numbers of cells expressed relative to fiber
number. The graphs show the relationship between the number of FA1 cells
located outside (A) or inside (B) merosin-stained muscle borders, and the
number of FA1 NCAM cells (A) or FA1 NCAM cells (B). Data are
from resting biopsies obtained from young healthy males; n 
 23. Note:
removal of the single data point with highest values in B changes r value to
0.717, P 
 0.0002.
Fig. 2. Numbers of satellite cells, as identified by NCAM, following a 36-km
run. Groups either consumed nonsteroidal anti-inflammatory drug (NSAID)
(n 
 5) or placebo (n 
 6). Values are means  SD and are expressed relative
to myonuclear number and as a percentage of preexercise (Pre) values.
*Significantly different from preexercise values, P  0.05.
Fig. 3. Proportion of FA1 cells from vastus lateralis muscle of untrained
(n 
 12) and endurance-trained (n 
 11) healthy individuals. Values are
expressed relative to the number of NCAM cells. *P
 0.0007. [Data for the
trained group are combined preexercise values from NSAID (n 
 5) and
placebo (n 
 6) groups.]
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groups for either the percentage of embryonic fibers or the
percentage of fibers with central nuclei.
DISCUSSION
The new findings presented in this study reveal increased
numbers of NCAM-stained cells in response to a 36-km run,
suggesting that satellite cells were activated to reenter the cell
cycle and proliferate with the exercise. While enhancement of
the satellite cell pool has been demonstrated in several previous
studies, this is, to our knowledge, the first study to show a
response in individuals who are highly trained and accustomed
to the exercise intervention. We also report here, for the first
time, data suggesting that ingestion of NSAIDs may attenuate
this response (Fig. 2), providing in vivo support for a role for
the COX pathway in satellite cell activity in humans. While
some authors have reported no effect of NSAIDs on satellite
cell activity or muscle regeneration (45), several studies have
demonstrated a negative effect of NSAID administration on
various stages of myogenesis and regeneration (2, 4, 31, 33, 49,
50). The results of those experiments are supported by the
present study, where no increase in the number of satellite
cells, as assessed by NCAM staining, was observed in response
to exercise in individuals who consumed NSAIDs.
The role of NSAIDS in satellite cell activity. Evidence for
inflammation as a catalyst for activation of satellite cells comes
from the many studies that have investigated the effects of
blocking inflammation, directly on satellite cells in vitro, and
also in animal models in vivo. Several other factors have also
been shown to be capable of activating satellite cells, including
hepatocyte growth factor (HGF) (1), nitric oxide synthase (43),
and the insulin-like growth factor-1 (IGF-1) isoform known as
mechanogrowth factor (17), while the IGF-1 isoform IGF-IEa,
along with other growth factors, acts to enhance proliferation
(36). The precise mechanisms by which these agents activate
satellite cells are not fully understood, but there is evidence for
some specific interactions. For example, it is known that HGF
acts on satellite cells via c-met, the HGF receptor expressed on
quiescent satellite cells (8). Similarly, the role for inflammatory
cells in satellite cell activation comes from the observation that
quiescent murine satellite cells also express VCAM-1, whose
coreceptor is found on infiltrating leukocytes (19). The influ-
ence of COX activity on myoblasts is through the conversion
of arachidonic acid to prostaglandins (PGs), which have been
shown to be important in muscle development (30), the differ-
ent PG subtypes being implicated in the different stages of
myoblast fusion (18). In the present study, COX-blocking
NSAIDs were given in amounts known to block PG synthesis,
and it has previously been demonstrated with the use of
microdialysis that NSAID administration resulted in a com-
plete drop in PGE2 interstitial tissue concentration (25). Thus
the present data support the view that COX-induced PG syn-
thesis is important for satellite cell activity.
PGs serve many physiological functions in skeletal muscle,
such as contributing to the regulation of blood flow (5, 32), and
it is possible that this effect in itself prevented satellite cells
from responding to the stimulus in the NSAID group, since this
would reduce the transport of other signaling agents to and
from the muscle. Although blood flow was not monitored in
the present study, and it is difficult to comment on the extent of
this effect, other data have shown that PG alone did not
influence blood flow in skeletal muscle during exercise (24).
While the likely function of NSAIDs is in the prevention of PG
synthesis through COX inhibition, it is also known that differ-
ent NSAIDs can act by various COX-independent mecha-
nisms, inhibiting some pathways and activating others (44).
We can therefore not rule out the possibility that pathways
other than the COX/PG pathway have contributed to the
attenuating effect of NSAIDs on satellite cell activity observed
in the present study. However, the lack of any increase in
satellite cell number with NSAIDs suggests that the presence
of PG is important for this response.
FA1 staining. Another finding of the present study was that
FA1 stained 25% more satellite cells (NCAM) in healthy
untrained individuals compared with trained individuals (Fig.
3). This is, to our knowledge, the first study that has quantita-
tively investigated the colocalization of FA1 and NCAM. It has
been suggested that FA1 is a marker of cells with regenerative
potential (12). With this in mind, together with the theory that
adult skeletal muscle might contain different subpopulations of
myogenic precursor cells, it is plausible that FA1 identifies a
subpopulation of myogenic precursor cells in human skeletal
muscle. This theory is supported by the fact that some of these
cells were observed to occupy the classic satellite cell position
under the basal lamina, whereas others were located outside the
muscle fiber. While the majority of FA1 cells were also
NCAM, 19% of all cells counted were FA1 NCAM, and
strong correlations between these data and the merosin/FA1
staining data suggest that the FA1 NCAM cells were
located outside the fibers (see Fig. 4). At this point of the
discussion it should be remembered that markers for identifi-
cation of myogenic precursor cells continue to be explored and
validated, in particular in adult human skeletal muscle during
events induced by exercise. Furthermore, it is possible that
expression of NCAM on myogenic precursor cells may not be
constant but could for example be conditional on their location
or activation status. While we cannot rule out the possibility
that FA1 is expressed in other cell types such as fibroblasts and
inflammatory cells, it is possible that these FA1 NCAM
cells are a myogenic precursor cell subpopulation that is either
1) migrating into the muscle fiber or 2) leaving it. In addition,
although it is not possible to determine the exact origin and
destination of these cells at this point, the presence of FA1
cells inside and outside the muscle cell is an interesting finding,
and that regular training influences the proportion of NCAM
FA1 cells supports the theory that FA1 labels a subpopula-
tion of myogenic precursor cells. With regard to why trained
athletes have a lower proportion of these cells compared with
untrained individuals, it is tempting to speculate that this is
indicative of a lower remaining regenerative potential in the
trained muscle. The basis for this speculation is that it has been
suggested that FA1 is present in cells with regenerative poten-
tial (12), and furthermore that it appears the proliferative
potential of satellite cells is limited (39); thus the many cycles
of damage and repair induced over many years of training
would result in a lower remaining capacity for cell division.
However, as the significance of FA1 staining remains to be
clarified, it is not possible to comment conclusively on these
findings at this time.
Satellite cells and exercise. This is the first study we are
aware of that has examined the influence of a single bout of
endurance running on satellite cells in trained individuals. The
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numbers of satellite cells at baseline were similar to those in
our untrained group and agree with satellite cell numbers in
young men at rest reported in some studies (21, 23, 34, 35),
although others have reported lower resting values (9, 10, 16,
37, 47). In some cases this discrepancy is likely to be due to the
different methods of detection used, i.e., electron microscopy
vs. immunohistochemistry, or the use of different antibodies,
e.g., Pax7 vs. NCAM. It would not be unexpected to find
higher numbers of satellite cells in endurance-trained individ-
uals, since Charifi et al. (6) reported increased satellite cell
numbers following a period of endurance training. However,
based on the similar levels of satellite cells (using an NCAM
antibody) observed in the untrained subjects in the present
study and elsewhere (21, 23, 34, 35), it appears that long-term
endurance training (5 yr) results in levels of satellite cells
comparable to untrained active individuals.
The unchanged levels of the proportion of FA1 cells with
36-km running in the present study are in contrast to the results
reported by Crameri et al. (9), where significantly higher levels
of FA1 cells were observed on days 4 and 8 postexercise.
The two major differences between these two studies were the
training status of the participants and the exercise interventions
employed. The subjects in the present study were well-trained
endurance runners who completed a single bout of exercise to
which they were already accustomed, whereas the untrained
volunteers in the study by Crameri et al. (9) performed one
bout of high-intensity eccentric exercise, which is likely to
have resulted in a much greater insult to the muscle. These
differences may also explain the difference between the two
studies in the magnitude of response of NCAM cells. Cra-
meri et al. (9) reported an increase of almost 200% in the
number of NCAM cells on day 4 postexercise, an increase
that was still evident by day 8. In the present study, the modest
27% increase in the placebo group was not observed until day
8 postexercise and is more in line with previous studies
involving periods of training lasting several months (6, 21, 26,
38). One obvious question concerns the purpose of the new
satellite cells reported in such studies. In adult muscle, one of
the main functions of satellite cells is to provide new myonu-
clei for maintenance and growth. No increased numbers of
myonuclei were observed in the present study, however, and it
is unlikely that enhancement of the satellite cell pool following
a single bout of exercise can be explained by replacing existing
myonuclei, since this occurs at a very low rate (42). Another
function of satellite cells is to produce new myofibers to fuse
with existing fibers to repair areas of damage induced by injury
or exercise. Healthy skeletal muscle can regenerate fully fol-
lowing exercise-induced damage, and this process would be a
reason for activation of satellite cells. Altered patterns of
regeneration, as assessed by embryonic myosin staining, have
been reported with NSAID administration following contrac-
tion-induced injury in rabbit skeletal muscle (33). Regenera-
tion was therefore also investigated in the present study, and
while some embryonic myosin-positive and dystrophin-nega-
tive fibers, as well as central nuclei, were observed, no statis-
tically significant effect of either exercise or NSAID ingestion
could be detected for these parameters. Furthermore, no sign of
muscle damage in the form of necrotic muscle fibers was
observed. It is likely that this is because the exercise was
something the subjects were accustomed to. While some stud-
ies have reported no increase in inflammation in skeletal
muscle with exercise (29), or increased inflammation following
multiple biopsies alone (28), there is evidence for acute and
chronic inflammatory responses in human skeletal muscle
following certain types of exercise, especially where eccentric
contractions are involved [reviewed by Clarkson and Hubal
(7)]. Despite the unaccustomed high-force muscle contractions
performed in the study by Crameri et al. (9), evidence of
necrosis was only observed in one of eight subjects, which
taken together with the results of the present study suggests
that satellite cells do not require muscle damage (as evidenced
by visible signs of necrosis at the light microscopy level) to be
stimulated to proliferate. Furthermore, it appears that the extent
of proliferation is influenced by the type of exercise and how
well the subjects are accustomed to it, a factor that is affected
by the prior training status of the individual. While the purpose
of the new satellite cells remains to be determined, it is
possible that they simply return to a quiescent state in the
absence of subsequent stimuli.
In conclusion, given the vital role satellite cells play in
skeletal muscle maintenance and regeneration, any factors that
interfere with their activity could negate the anabolic effects
exerted by exercise, and while the precise mechanism by which
the COX pathway acts on satellite cells and the ensuing events
in the repair or hypertrophy process remains unclear, there is
mounting evidence for a positive regulatory effect on satellite
cell activity. This is relevant for the vast number of athletes
who consume NSAIDs to continue training when faced with
muscle soreness or injury, and also for the various disease
conditions, such as osteoarthritis, where NSAIDs are pre-
scribed. In conclusion, the data from this study suggest a
negative regulatory effect of NSAIDs on the number of
NCAM cells in human muscle, supporting the view that the
COX pathway is important for normal satellite cell activity.
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